ROS production and their influence on the cellular antioxidative system in human erythrocytes incubated with daunorubicin and glutaraldehyde

Environmental Toxicology and Pharmacology

Volumn 36, Issue 1, 2013, Pages 171-181

  Marczak, Agnieszka ^a   Bukowska, Bozena ^a  

^a UNIVERSITY OF LODZ   (Poland)

Author keywords

Anthracyclines; Drug carriers; Glutaraldehyde; Reactive oxygen species

Indexed keywords

DAUNORUBICIN; DRUG CARRIER; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTARALDEHYDE; GLUTATHIONE REDUCTASE; PHOSPHATIDYLSERINE; REACTIVE OXYGEN METABOLITE;

ARTICLE; CELL SURFACE; CELL VIABILITY; CONTROLLED STUDY; CROSS LINKING; DRUG DELIVERY SYSTEM; DRUG EFFECT; ENZYME ACTIVITY; ERYTHROCYTE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; FLUOROMETRY; HEMOLYSIS; HUMAN; HUMAN CELL; INCUBATION TIME; OXIDATION; PRIORITY JOURNAL;

ANTIBIOTICS, ANTINEOPLASTIC; CATALASE; CELL SURVIVAL; CELLS, CULTURED; CROSS-LINKING REAGENTS; DAUNORUBICIN; ERYTHROCYTES; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUTARAL; GLUTATHIONE; GLUTATHIONE REDUCTASE; HUMANS; METHEMOGLOBIN; OXIDATION-REDUCTION; PHOSPHATIDYLSERINES; REACTIVE OXYGEN SPECIES;

EID: 84876718801     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2013.03.020     Document Type: Article

References (67)

1. Aebi H. Catalase in vitro. Methods in Enzymology 1984, vol. 105:121-126. Academic Press, Orlando.
2. Akerboom T.P.M., Sies H. Assay of glutathione, glutathione disulfide and glutathione mixed disulfides in biological samples. Methods Enzymol. 1981, 77:373-382.
3. Aruoma O.I., Halliwell B., Hoey B.M., Butle J. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous amid. Free Rad. Biol. Med. 1989, 6:593-597.
4. Ataullakhanov F.I., Kulikova E.V., Vitvitsky V.M. Reversible binding of anthracyclines treated with glutaraldehyde. Biotechnol. Appl. Biochem. 1996, 24:241-244.
5. Baldassarre F., Vergaro V., Scarlino F., De Santis F., Lucarelli G., Torre A.D., Ciccarella G., Rinaldi R., Giannelli G., Leporatti S. Polyelectrolyte capsules as carriers for growth factor inhibitor delivery to hepatocellular carcinoma. Macromol. Biosc. 2012, 12:656-665.
6. Bartosz G. Druga Twarz Tlenu. Wolne Rodniki w Przyrodzie 2008, Wydawnictwo Naukowe PWN, Warszawa.
7. Belleli A., Benedetti P.L., Coletta M., Ippoliti R., Brunori M. Human erythrocytes cross-linked with glutaraldehyde general properties and significance as a blood substitute. Biochem. Biophys. Res. Commun. 1988, 156:970-977.
8. Bladeren P.J. Glutathione conjugation as a bioactivation reaction. Chem. Biol. Interact. 2000, 129:61-76.
9. Büchner T., Berdel W.E., Wörmann B., Schoch C., Haferlach T., Schnittger S., Kern W., Aul C., Lengfelder E., Schumacher A., Reichle A., Staib P., Balleisen L., Eimermacher H., Grüneisen A., Rasche H., Sauerland M.C., Heinecke A., Mesters R.M., Serve H.L., Kienast J., Hiddemann W. Treatment of older patients with AML. Crit. Rev. Oncol. Hematol. 2005, 56:247-259.
10. Bukowska B. Glutathione functions and factors decreasing its concentration (in Polish). Med. Pr. 2005, 56:69-80.
11. Carlberg I., Mannervik B. Purification and characterization of flavoenzyme glutathione reductase from rat liver. J. Biol. Chem. 1975, 250:5475-5480.
12. Clark M.R. Senescence of red blood cells: progress and problems. Physiol. Rev. 1988, 68:503-554.
13. Dalle-Donne I., Rossi R., Colombo R., Giustarini D., Milzani A. Biomarkers of oxidative damage in human disease. Clin. Chem. 2006, 52:601-623.
14. Davies K.J.A., Doroshow J.H. Redox cycling of anthracyclines by cardiac mitochondria. Anthracycline radical formation by NADH dehydrogenase. J. Biol. Chem. 1986, 261:3060-3067.
15. Dekhuijzen P.N.R. Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease. Eur. Respir. J. 2004, 23:629-636.
16. Drabkin D.I. Spectrophotometric studies. XIV the crystalographic and optical properties of the hemoglobin of man in comparison with these of other species. J. Biol. Chem. 1946, 164:703-723.
17. Efferth T., Schwarzl S.M., Smith J., Osieka R. Role of glucose-6-phosphate dehydrogenase for oxidative stress and apoptosis. Cell Death Differ. 2006, 13:527-528.
18. Ellman G.K. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959, 82:70-77.
19. Evelhoch J.L. pH and therapy of human cancers. Novartis Found. Symp. 2001, 240:68-80.
20. Fan H., Dash A.K. Effect of cross-linking on the in vitro release kinetics of doxorubicin from gelatin implants. Int. J. Pharm. 2001, 213:110-116.
21. Fars K.A. Pravastatin provides antioxidant activity and protection of erythrocytes loaded primaquine. Int. J. Med. Sci. 2010, 7:358-365.
22. Feinstein E., Canadni E., Weiner L.M. Dependence of nucleic acid degradation on in situ free radical production by adriamycin. Biochemistry 1998, 32:13156-13161.
23. Fujii T., Hamaoka R., Fujii J., Taniguchi N. Redox capacity of cells affects inactivation of glutathione reductase by nitrosative stress. Arch. Biochem. Biophys. 2000, 378:123-130.
24. Galaris D., Skiada V., Barbout A. Redox signaling and cancer: the role of "labile" iron. Cancer Lett. 2008, 266:21-29.
25. Gerweck L. The pH difference between tumor and normal tissue offers a tumor specific target for the treatment of cancer. Drug Resist. Updat. 2000, 3:49-50.
26. Giardina B., Messana I., Catena R., Cascagnola M. The multiple function of hemoglobin. Biochem. Mol. Biol. 1995, 30:165-196.
27. Goodman J., Hochstein P. Generation of free radicals and lipid peroxidation by redox cycling of adriamycin and daunomycin. Biochem. Biophys. Res. Commun. 1977, 77:797-803.
28. Gopal V.S., Ranjith Kumar A.N., Usha N.A., Karthik A., Udupa N. Effective drug targeting by erythrocytes as carrier systems. Curr. Trends Biotechnol. Pharm. 2007, 1:18-33.
29. Grasso S., Scifo C., Cardile V., Gulino R., Renis M. Adaptative responses to the stress induced by hyperthermia or hydrogen peroxide in human fibroblasts. Exp. Biol. Med. 2003, 228:491-498.
30. Guo J., Zhou J., Ying X., Men Y., Li R.J., Zhang Y., Du J., Tian W., Yao H.J., Wang X.X., Ju R.J., Lu W.L. Effects of stealth liposomal daunorubicin plus tamoxifen on the breast cancer and cancer stem cells. J. Pharm. Pharm. Sci. 2010, 13:136-151.
31. Harisa G., El-din I., Ibrahim M.F., Alanazi F.K. Characterization of human erythrocytes as potential carrier for pravastatin: an in vitro study. Int. J. Med. Sci. 2011, 8:222-230.
32. Julicher R.H.M., van der Laarse A., Sterrenberg L., Treslong C.H.F., Basr A., Noordhoek J. The involvement of an oxidative mechanism in the adriamycin-induced toxicity in neonatal rat heart cell cultures. Res. Commun. Chem. Pathol. Pharmacol. 1985, 47:35-47.
33. Kagan V.E., Borisenko G.G., Tyurina Y.Y., Tyurin V.A., Jiang J., Potapovich A.L., Kini V., Amoscato A.A., Fujii Y. Oxidative lipidomics of apoptosis: redox catalytic interactions of cytochrome c with cardiolipin and phosphatidylserine. Free Radic. Biol. Med. 2004, 15:1963-1985.
34. 2O-saturated buffers. Rad. Phys. Chem. 2008, 77:775-780.
35. Lejeune A., Moorjani M., Gicquaud C., Lacroix J., Poyet P., Gaudreault R.C. Nanoerythrosome, a new derivative of erythrocyte ghost: preparation and antineoplastic potential as drug carrier for daunorubicin. Anticancer Res. 1994, 14:915-920.
36. Marczak A. Apoptosis in human erythrocytes. Post. Biol. Kom. 2005, 32:359-373.
37. Marczak A. Fluorescence anisotropy of membrane fluidity probes in human erythrocytes incubated with anthracyclines and glutaraldehyde. Bioelectrochemistry 2009, 74:236-239.
38. Marczak A., Jóźwiak Z. Damage to the cell antioxidative system in human erythrocytes incubated with idarubicin and glutaraldehyde. Toxicol. In Vitro 2009, 23:1188-1194.
39. Marczak A., Jóźwiak Z. Disturbances of the asymmetry of phosphatidylserine in the cell membrane - the latest data. Post. Biol. Kom. 2007, 34:231-240.
40. Marczak A., Jóźwiak Z. The interaction of DNR and glutaraldehyde with cell membrane proteins leads to morphological changes in erythrocytes. Cancer Lett. 2008, 260:118-126.
41. Marczak A., Walczak M., Jóźwiak Z. The combined effect of IDA and glutaraldehyde on the erythrocyte membrane proteins. Int. J. Pharmaceut. 2007, 335:154-162.
42. Masquelier M., Vitols S. Drastic effect of cell density on the cytotoxicity of daunorubicin and cytosine arabinoside. Biochem. Pharmacol. 2004, 67:1639-1646.
43. Meister A., Anderson M.E. Glutathione. Annu. Rev. Biochem. 1983, 52:711-760.
44. Minotti G., Menna P., Salvatorelli F., Cairo G., Gianni L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol. Rev. 2004, 56:185-229.
45. Mizutani H., Tada-Oikawa S., Hiraku Y., Kojima M., Kawanishi S. Mechanizm of apoptosis induced by doxorubicin through the generation of hydrogen peroxide. Life Sci. 2005, 76:1439-1453.
46. Munoz-Castaneda J.R., Muntane J., Munoz M.C., Bujalance I., Montilla P., Tunez I. Estradiol and catecholestrogens protect against adriamycin-induced oxidative stress in erythrocytes of ovariectomized rats. Toxicol. Lett. 2006, 160:196-203.
47. Nagababu E., Chrest F.J., Rifkind J.M. The origin of red cell fluorescence caused by hydrogen peroxide treatment. Free Radic. Biol. Med. 2000, 29:659-663.
48. Nagababu E., Chrest F.J., Rifkind J.M. Hydrogen-peroxide-induced heme degradation in red blood cells: the protective roles of catalase and glutathione peroxidase. Biochim. Biophys. Acta 2003, 1620:211-217.
49. Ness K.K., Armenian S.H., Kadan-Lottick N., Gurney J.G. Adverse effects of treatment in childhood acute lymphoblastic leukemia: general overview and implications for long-term cardiac health. Expert. Rev. Hematol. 2011, 4:185-197.
50. Nurgalieva Z., Liu C.C., Du X.L. Chemotherapy use and risk of bone marrow suppression in a large population-based cohort of older women with breast and ovarian cancer. Med. Oncol. 2011, 28:716-725.
51. Okuda K., Urabe I., Yamada Y., Okada H. Reaction of glutaraldehyde with amino and thiol compounds. J. Ferment. Bioengine 1991, 71:100-105.
52. Ozturk O., Gumuslu S. Age-related changes of antioxidant enzyme activities, glutathione status and lipid peroxidation in rat erythrocytes after heat stress. Life Sci. 2004, 75:1551-1565.
53. Paranka M.C., Dorr R.T. Effect of doxorubicin on glutathione and glutathione-dependent enzymes in cultured rat heart cells. Anticancer Res. 1994, 14:2047-2052.
54. Patel R.P. An overview of resealed erythrocyte drug delivery. J. Pharm. Res. 2009, 2:1008-1012.
55. Richard D., Hollender P., Chénais B. Involvement of reactive oxygen species in aclarubicin-induced differentiation and invasiveness of HL-60 leukemia cells. Int. J. Oncol. 2002, 21:393-399.
56. Schafer F.Q., Buettner G.R. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic. Biol. Med. 2001, 30:1191-1212.
57. Setua S., Menon D., Asok A., Nair S., Koyakutty M. Folate receptor targeted, rare-earth oxide nanocrystals for bi-modal fluorescence and magnetic imaging of cancer cells. Biomaterials 2010, 31:714-729.
58. Simunek T., Stérba M., Popelová O., Adamcová M., Hrdina R., Gersl V. Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron. Pharmacol. Rep. 2009, 61:154-171.
59. Stěrba M., Popelová O., Lenčo J., Fučíková A., Brčáková E., Mazurová Y., Jirkovský E., Simůnek T., Adamcová M., Mičuda S., Stulík J., Geršl V. Proteomic insights into chronic anthracycline cardiotoxicity. J. Mol. Cell Cardiol. 2011, 50:849-862.
60. Sztiller M., Puchała M., Kowalczyk A., Bartosz G. The influence of ferrylhemoglobin and methemoglobin on the human erythrocyte membrane. Redox Rep. 2006, 11:263-271.
61. Szwarocka A., Kowalczyk A., Łubgan D., Jóźwiak Z. The combined effect of IDA and glutaraldehyde on the properties of human erythrocytes. Int. J. Pharmaceut. 2001, 220:43-51.
62. Tabaczar S., Koceva-Chyła A., Czepas J., Pienia{ogonek}żek A., Piasecka-Zelga J., Gwoździński K. Nitroxide pirolin reduced oxidative stress generated by doxorubicin and docetaxel in blood plasma of rats bearing mammary tumor. J. Physiol. Pharmacol. 2012, 63:153-163.
63. Tabatabaie T., Floyd R.A. Susceptibility of glutathione peroxidase and glutathione reductase to oxidative damage and the protective effect of spin trapping agents. Arch. Biochem. Biophys. 1994, 314:112-119.
64. Tyurina Y.Y., Tyurin V.A., Zhao Q., Djukic M., Quinn P.J., Pitt B.R., Kagan V.E. Oxidation of phosphatidylserine: a mechanism for plasma membrane phospholipid scrambling during apoptosis?. Biochem. Biophys. Res. Commun. 2004, 324:1059-1064.
65. Xu J., Ma L., Liu Y., Xu F., Nie J., Ma G. Design and characterization of antitumor drug paclitaxel-loaded chitosan nanoparticles by W/O emulsions. Int. J. Biol. Macromol. 2012, 50:438-443.
66. Ying X., Wen H., Yao H.J., Zhang Y., Tian W., Zhang L., Ju R.J., Wang X.X., Yu Y., Lu W.L. Pharmacokinetics and tissue distribution of dual-targeting daunorubicin liposomes in mice. Pharmacology 2011, 87:105-114.
67. Zatorska A., Jóźwiak Z. Involvement of glutathione and glutathione-related enzymes in the protection of normal and trisomic human fibroblasts against daunorubicin. Cell Biol. Int. 2002, 26:383-391.